Impaired β-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock

Abstract
To determine whether myocardial hyporesponsiveness to administered catecholamines occurs in human sepsis and whether this phenomenon is associated with impaired β-adrenergic receptor stimulation of cyclic adenosine monophosphate. Prospective study. Medical ICU in a university hospital. Normal human volunteers (n = 7), critically ill patients who were not septic (n = 9), septic patients not in shock (n = 16), and septic patients in shock (n = 17). Pulmonary artery catheter-derived hemodynamic data were obtained in patients with sepsis and septic shock. Isoproterenol and sodium fluoride-stimulated cyclic adenosine monophosphate accumulations were measured in circulating lymphocytes. The hemodynamic response to sequential infusions of dobutamine, 5 and 10 μg/ kg/min, was obtained in septic and septic shock patients. Baseline hemodynamic values for mean arterial pressure, cardiac index, left ventricular stroke work index, and oxygen delivery index at approximately 2 days after the onset of sepsis were significantly lower in septic shock patients compared with septic (nonshock) patients (p < .01, p < .05, p < .001, p < .01, respectively). Isoproterenol-and sodium fluoride-stimulated cyclic adenosine monophosphate accumulations were significantly reduced in septic shock patients compared with those accumulations observed in septic patients (p < .01 and p < .001, respectively). The heart rate response to 10 μg/ kg/min of dobutamine was significantly (p < .01) lower in septic shock patients compared with septic patients. In patients with septic shock, impaired β-adrenergic receptor stimulation of cyclic adenosine monophosphate is associated with myocardial hyporesponsiveness to catecholamines, suggesting that β-adrenergic receptor dysfunction may contribute to the reduced myocardial performance observed in this shock state. (Crit Care Med 1993; 21:31–39)

This publication has 0 references indexed in Scilit: